MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Goals for Improvement in Essential Tremor Patients Following Focused Ultrasound VIM Thalamotomy

    L. O'Brien, K. Lyons, V. Sharma, R. Pahwa (Kansas City, USA)

    Objective: To report the most common expectations prior to focused ultrasound (FUS) treatment in essential tremor (ET) patients using the Goal Attainment Scaling method (GAS).…
  • 2022 International Congress

    Phase-amplitude coupling between beta power and high frequency oscillations as a sensitive marker of parkinsonian state.

    M. Bočková, M. Lamoš, P. Daniel, M. Baláž, J. Chrastina, I. říha, I. Rektor (Brno, Czech Republic)

    Objective: The aim of this work was to study the potential clinical usefulness of the phase-amplitude coupling (PAC) between beta power and high frequency oscillations (HFO´s).…
  • 2022 International Congress

    Ballet for Parkinson’s disease, a new concept: Remote delivery via the English National Ballet’s Dance for Parkinson’s programme

    A. Podlewska, R. Davis, L. Batzu, P. Tall, F. Derbyshire-Fox, A. Hartley, N. Sevdalis, A. Woods, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To explore the characteristics and subjective outcomes for People with Parkinson’s (PwP) attending online Dance for Parkinson’s sessions professionally delivered by the English National…
  • 2022 International Congress

    Safety and tolerability of Nilotinib in patients with Huntington’s disease

    K. Anderson (Washington, USA)

    Objective: To investigate the safety and tolerability of nilotinib, an FDA-approved drug for leukemia, in individuals with Huntington’s disease (HD). Background: Previous clinical studies in…
  • 2022 International Congress

    Comorbid neuropathological features in multiple system atrophy

    H. Sekiya, S. Koga, A. Murakami, D. Dickson (Jacksonville, USA)

    Objective: To elucidate the distribution of comorbid neuropathology in multiple system atrophy (MSA) and its clinical correlation. Background: Multiple protein accumulations are often present in…
  • 2022 International Congress

    Administration of the mGlu2 positive allosteric modulator BINA as monotherapy improves parkinsonism in the MPTP-lesioned marmoset

    C. Kwan, A. Hamadjida, I. Frouni, S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)

    Objective: To assess the effect of selective metabotropic glutamate type 2 (mGlu2) receptor activation on parkinsonism as monotherapy in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned marmoset compared to…
  • 2022 International Congress

    Prevalence of sleep disorders in Parkinson’s disease patients at a Brazilian movement disorders center in 2022

    L. Castanheira, C. Lobo, I. Oliveira, L. de Almeida, G. Valença (Salvador, Brazil)

    Objective: To describe the prevalence of the main sleep disorders in patients with Parkinson's disease at a referral outpatient clinic for movement disorders. Background: Parkinson's…
  • 2022 International Congress

    A Man Who Has Been Presenting with Pruritus and Myoclonus

    EJ. Choi, DG. Lee, AR. Lim (Gumi, Republic of Korea)

    Objective: While various neurological symptoms of sparganosis including have been reported, this is the first documented instance in which sparganosis presented with myoclonus. Background: Sparganosis…
  • 2022 International Congress

    DaTscan striatal binding ratio dynamics in mutations carriers at risk for Parkinson’s disease: A 2-year prospective study

    A. Droby, D. Atias, H. Lerman, RM. Hutchison, L. Yahimovich, J. Cedarbaum, E. Even Sapir, N. Giladi, A. Mirelman, A. Thaler (Tel Aviv, Israel)

    Objective: To investigate the temporal dynamics of striatal binding ratios (SBRs) among individuals with Parkinson's disease (PD)-related mutations and its' association with likelihood ratio (LR)…
  • 2022 International Congress

    Gait Characteristics from Daily Life Increase Ability to Predict Future Falls in People with Parkinson’s Disease

    V. Shah, J. Mcnames, G. Harker, P. Carlson-Kuhta, J. Nutt, M. El Gohary, K. Sowalsky,, M. Mancini, F. Horak (Portland, USA)

    Objective: We investigated if digital measures of different aspects of gait (walking and turning) from a week of daily activities increase discriminative ability to predict…
  • « Previous Page
  • 1
  • …
  • 109
  • 110
  • 111
  • 112
  • 113
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley